Synthesis and Antitumor Activity of Poly(organophosphazene)/Doxorubicin Conjugates

References

1. Cancer Chemotherapy Handbook Doff, R. T.;Van Hoff, D. D
2. Crit. Rev. Ther. Drug Carrier Syst. v.9 no.2 Seymour, I. W
3. Rev. Ther. Drug. Carrier. Syst. v.6 no.3 Maeda, H.;Matsumura, Y
4. Cancer Res. v.46 no.5 Matsumura, Y.;Maeda, H
5. Bioconjugate Chem. v.3 no.5 Maeda, H.;Seymour, L. W.;Miyamoto, Y
6. Br. J. Cancer v.70 Symour, L. W.;Ulbrich, K.;Steyger, P. S.;Brereto, M.;Bubr, V.;Strohalm, J.;Duncan, R
7. Proceed Int'l. Symp control. Rel. Bioact. Mater. v.24 Maeda, H
8. Int. J. Pharmaceutics v.153 Sohn, Y. S.;Baek, H.-G.;Cho, Y. H.;Lee, Y. A.;Jung, O.-S.;Lee, C. O.;Kim, Y. S
9. J. Control. Rel. v.55 Song, S.-C.;Shon, Y. S
10. Macromolcules v.28 Sohn, Y. S.;Baek, H.-G.;Cho, Y. H.;Jung, O.-S
11. Chemistry of the amino acids Greenstein, J. P.;Winitz, M
12. J. Am. Chem. Soc. v.73 Vaughan, J. R
13. Soluble polymers as targetable drug carriers Jiliano, R. L